Houston, TX Pulmotect, Inc., a clinical-stage biotechnology company, announced positive topline results from the first of two Phase-2 clinical trials undertaken with the support of the US Department of Defense (DOD) to evaluate PUL-042 against COVID-19. Patients treated with … Read More »

Dear Friends of PharmaVOICE, After 20 years of being your trusted source as the VOICE of the industry and the convener of the most influential thought leaders across the life-sciences ecosystem, PharmaVOICE is now part of Industry Dive, a leading business journalism company. … Read More »

POWERSEAL Family of Devices Completes the Olympus Energy Portfolio, Offers Physicians Improved Performance and Ergonomics Olympus Corporation (Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced the launch of the first devices in the new POWERSEAL … Read More »

PLEASANTON, CA — Sept. 16, 2021 — Veeva Systems (NYSE: VEEV) today announced that Emmes is standardizing on Veeva Development Cloud applications across functional areas to enable greater speed and compliance. The company will use applications in Vault Clinical, Vault Quality … Read More »

CHICAGO, Sept. 21, 2021 – AbelsonTaylor has promoted Dave Schafer to director of digital production and quality assurance. Working closely with the agency’s creative, account and project management groups, he will manage digital producers and quality assurance specialists to … Read More »

Ahead of the first Pharmapack Europe to be held in nearly 18-months, Informa has released the results of its global drug delivery and packaging survey, with the USA once again leading ‘drug delivery and device innovation’, but lagging behind all major European nations on sus … Read More »

A limited understanding and ability to articulate use cases is holding back the development of quantum computing in life sciences, Pistoia Alliance and QED-C survey finds Boston, 16 September, 2021, The Pistoia Alliance, a global, not-for-profit alliance that advocates for g … Read More »

The U.S. Food and Drug Administration (FDA) today awarded a number of approvals for Takeda Pharmaceutical’s candidate drug EXKICITY in the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer. Takeda was granted priority review and recei … Read More »

Swiss drugmaker Vifor Pharma (VTX: VIF0N) and USA-based Travere Therapeutics (Nasdaq: TVTX) have entered into a joint collaboration and licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand. Sparsentan is a novel investigational pro … Read More »

The Swedish software company Qlucore has signed an agreement with Neoscreen Medical Ltd., Qlucore’s first contract for its new solutions for precisions diagnostics. Neoscreen will use Qlucore’s highly configurable for RNA-seq based diagnostics software to facilitate and spee … Read More »

Milestone reached with Dartmouth-Hitchcock Medical Center (New Hampshire’s top ranked hospital) with its recent acceptance to Eastern Orthopaedic Association 2021 NEW YORK – September 16, 2021 – Force Therapeutics, the leading patient engagement platform and research network … Read More »

(Atlanta, GA, September 15, 2021) — MERGE, a premium storytelling technology agency that promotes health, wealth and happiness, today announced Kelly Tkac as the new Senior Vice President Group Business Development Leader in the firm’s South region. In this role, Tkac will b … Read More »

MIAMI – September 15, 2021 – ArisGlobal, the leading provider of life sciences software that automates core drug development with its end-to-end drug development technology platform, LifeSphere®, today announced the leading speakers for its upcoming Breakthrough2021 Conferen … Read More »

Dive Brief: Theravance Biopharma plans to lay off an estimated 270 employees, or roughly 75% of its workforce, in a bid by its leadership to reduce costs during a major shift at the company. Around three-fourths of the layoffs are slated for November, with the rest expected … Read More »

Early detection of chronic, hereditary conditions will enable population health management PHOENIX – September 14, 2021 – Tesis Labs, the leader in targeted genetic sequencing, announced it has been selected by Premier Health, an accountable care organization (ACO) serving c … Read More »

Avoiding contrast dyes for imaging tests not necessary if concerned about iodine allergy, peer-reviewed study concludes SOUTH SAN FRANCISCO, September 15, 2021— FDB (First Databank), the leading provider of drug and medical device knowledge that helps healthcare professional … Read More »

CAMBRIDGE, Mass.–(BUSINESS WIRE)– Amylyx Pharmaceuticals, Inc. today announced its intention to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for AMX0035 (sodium phenylbutyrate (PB) and taurursodiol (TURSO)) for the treatment of amyotroph … Read More »

The Novo Nordisk Foundation, part of the Danish pharma Novo Group, is stumping up $47.5 million for a new research collab between the Broad Institute of MIT and Harvard. Together, and with the seeding cash, the groups are launching the Novo Nordisk Foundation Center for Geno … Read More »

With BioHale® Trehalose, the latest addition to the BioHale® portfolio line, DFE Pharma expands its offering of stabilizers for biologics while providing further security of supply. Goch, Germany (15 September 2021) – DFE Pharma, a global leader in pharmaceutical excipient s … Read More »

(LONDON UK) – Quanticate, a leading global data-focused Clinical Research Organization (CRO), has named Nick Darbey as the company’s Executive Vice President of Business Development. Drawing on Darbey’s proven track record of growing CROs, Quanticate will leverage his busine … Read More »